Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2000
12/21/2000WO2000050020A3 Use of sulfamate derivatives for treating impulse control disorders
12/21/2000WO2000048631A3 Adjuvant and cell maturation agent
12/21/2000WO2000047580A3 Phenyl urea and phenyl thiourea derivatives
12/21/2000WO2000045791A3 Method for controlling liposome size
12/21/2000WO2000045167A3 Non-invasive method for detecting target rna
12/21/2000WO2000044710A3 Acetylenic aryl sulfonamide and phosphinic acid amide hydroxamic acid tace inhibitors
12/21/2000WO2000044709A3 ACETYLENIC α-AMINO ACID-BASED SULFONAMIDE HYDROXAMIC ACID TACE INHIBITORS
12/21/2000WO2000044367A3 A pharmaceutical composition of complex carbohydrates and essential oils and methods of using the same
12/21/2000WO2000044361A3 Highly purified ethyl epa and other epa derivatives for psychiatric and neurological disorders
12/21/2000WO2000038660A3 Use of bisphosphonates for the prevention and treatment of infectious processes
12/21/2000WO2000032201A3 Use of 17-ketosteroids for the treatment of malaria and trypanosomiasis
12/21/2000WO2000031094A3 Benzylglycosylamides as inhibitors of smooth muscle cell proliferation
12/21/2000WO2000027374A3 The use of excitatory amino acid transporter inhibitors to reduce cns white matter injury
12/21/2000WO2000007577A8 Phosphatidylcholine as a medicament for the protection of mucosa
12/21/2000WO1999059572A8 Gamma-aminobutyric acid derivatives containing, solid compositions and process for preparing the same
12/21/2000DE19928312A1 Arzneimittelzubereitung mit verzögerter Wirkstoffabgabe Pharmaceutical preparation with delayed release of active ingredient
12/21/2000DE19928146A1 New 3-benzylamino-benzothienopyrimidine derivatives inhibit phosphodiesterase V and are useful for treating cardiac insufficiency and impotence
12/21/2000DE19928112A1 Balanced mixtures of Guerbet alcohols, including new 2-hexyl-1-tetradecanol, useful as oil components of cosmetic and pharmaceutical compositions
12/21/2000DE19927689A1 Oral dosage formulation containing tramadol and diclofenac, useful for treating pain, contains the active ingredients in separate subunits
12/21/2000DE19927688A1 Multi-layered tablet containing tramadole and diclofenac, useful for treating pain, has separating layer between active ingredient layers
12/21/2000CA2689997A1 Mono- and disubstituted 3-propyl gamma-aminobutyric acids
12/21/2000CA2686633A1 Combination therapy for effecting weight loss and treating obesity
12/21/2000CA2412345A1 Antagonism of immunostimulatory cpg-oligonucleotides by 4-aminoquinolines and other weak bases
12/21/2000CA2390946A1 49 human secreted proteins
12/21/2000CA2387696A1 48 human secreted proteins
12/21/2000CA2384339A1 New bispidine compounds useful in the treatment of cardiac arrhythmias
12/21/2000CA2383048A1 49 human secreted proteins
12/21/2000CA2382769A1 42 human secreted proteins
12/21/2000CA2382748A1 50 human secreted proteins
12/21/2000CA2381322A1 Substituted heterocycle fused gamma-carbolines
12/21/2000CA2379048A1 Pharmaceutical compositions with wound healing or anti-complementary activity comprising a dextran derivative
12/21/2000CA2378745A1 Ligand-conjugated oligomeric compounds
12/21/2000CA2377397A1 Il-8 receptor antagonists
12/21/2000CA2377395A1 New bispidine compounds useful in the treatment of cardiac arrhythmias
12/21/2000CA2377391A1 Il-8 receptor antagonists
12/21/2000CA2377386A1 Il-8 receptor antagonists
12/21/2000CA2377341A1 Il-8 receptor antagonists
12/21/2000CA2377334A1 Compositions and systems for the treatment of hyperpigmentation
12/21/2000CA2377325A1 New bispidine compounds useful in the treatment of cardiac arrhythmias
12/21/2000CA2377320A1 Methods for modulating fxr receptor activity
12/21/2000CA2377232A1 Prophylactic, therapeutic and industrial antioxidant compositions enhanced with stabilized atomic hydrogen/free electrons and methods to prepare and use such compositions
12/21/2000CA2377153A1 1-(4-sulfamylaryl)-3-substituted-5-aryl-2-pyrazolines as inhibitors of cyclooxygenase-2
12/21/2000CA2376970A1 Thermogenesis-associated genes and thermogenesis-associated proteins of plant
12/21/2000CA2376956A1 Charged compounds facilitate viral transduction of cells
12/21/2000CA2376933A1 Methods and compositions for control of bone formation via modulation of leptin activity
12/21/2000CA2376921A1 Nasal delivery of apomorphine
12/21/2000CA2376909A1 Neuroprotective and retinoprotective ophthalmologic medicines
12/21/2000CA2376865A1 Compositions and methods comprising morphine gluconate
12/21/2000CA2376851A1 Synergistic antibacterial combination
12/21/2000CA2376715A1 Aminotetralin derivative for the therapy of cardiovascular diseases
12/21/2000CA2376675A1 Antagonists of bmp and tgf.beta. signalling pathways
12/21/2000CA2376667A1 Gene expression modulated in gastrointestinal inflammation
12/21/2000CA2376630A1 Induction of vascular endothelial growth factor (vegf) by the serine/threonine protein kinase akt
12/21/2000CA2376467A1 Hyaluronidase from the hirudinaria manillensis, isolation, purification and recombinant method of production
12/21/2000CA2376441A1 Estrogen receptor
12/21/2000CA2376389A1 Cloning and expression of a novel 5-ht4 receptor
12/21/2000CA2376302A1 Pharmaceutical composition comprising no or at least a no donor compound or another compound capable of releasing or inducing no fromation in cells
12/21/2000CA2376296A1 Urea substituted imidazoquinolines
12/21/2000CA2376274A1 Anhydrous antiperspirant cream compositions having improved perfume longevity
12/21/2000CA2376217A1 Novel formulations comprising lipid-regulating agents
12/21/2000CA2376067A1 Use of paclitaxel and steroid derivatives as aromatase inhibitors for the treatment of cancer
12/21/2000CA2375920A1 Compounds
12/21/2000CA2375878A1 Dithiepino[6,5-b]pyridines, and related compositions and methods
12/21/2000CA2375851A1 1-azatricyclic-4-benzylpiperazines
12/21/2000CA2375848A1 Optically active pyrrolopyridazine compounds
12/21/2000CA2375841A1 New bispidine compounds useful in the treatment of cardiac arrhythmias
12/21/2000CA2375825A1 Complement-resistant non-mammalian dna viruses and uses thereof
12/21/2000CA2375812A1 Derivatives of 4'-demycarosyl-8a-aza-8a-homotylosin
12/21/2000CA2375797A1 Organosilyl compounds having nuclear hormone receptor modulating activity
12/21/2000CA2375551A1 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits
12/21/2000CA2375511A1 (z)-styryl acetoxyphenyl sulfides as cyclooxygenase inhibitors
12/21/2000CA2374616A1 Rhodanine derivatives for use in a method of inhibiting amyloid protein aggregation and imaging amyloid deposits
12/21/2000CA2374555A1 Thiol derivative, metallo-beta-lactamase inhibitors
12/21/2000CA2374239A1 Substituted heterocycle fused gamma-carbolines
12/21/2000CA2373920A1 Substituted heterocycle fused gamma-carbolines
12/21/2000CA2373394A1 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits using isoindoline derivatives
12/21/2000CA2372558A1 Pharmaceutical preparation containing modifications of surfactant protein b (sp-b) and surfactant protein c (sp-c)
12/21/2000CA2370316A1 Rhodanine derivatives and their use in inhibiting and imaging amyloids
12/21/2000CA2340663A1 Antiviral indoleoxoacetyl piperazine derivatives
12/21/2000CA2340375A1 Agent for enhancing accumulation of drugs in tumor tissues
12/21/2000CA2340120A1 Transdermally delivered aspirin
12/20/2000EP1061085A2 Synthetic catalytic oligonucleotides
12/20/2000EP1061081A1 7-Oxo-2,3,7,14-tetrahydro-1H-benzo[b]pyrano[3,2-h]acridine carboxylate derivatives, process for their preparation and pharmaceutical compositions containing them
12/20/2000EP1061077A1 Novel pyridazine derivatives and drugs containing the same as the active ingredient
12/20/2000EP1061073A1 (R-(R*R*))-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl-3-phenyl-4((phenylamino)-carbonyl)-1H-pyrrole-1-heptanoic acid, its lactone form and salts thereof
12/20/2000EP1060750A2 Method for treating amyloidosis
12/20/2000EP1060749A1 Aqueous pharmaceutical composition comprising Tezosentan
12/20/2000EP1060744A1 Preventives/remedies for osteoporosis
12/20/2000EP1060743A1 Oral cisapride dosage forms with an extended duration
12/20/2000EP1060742A1 Interstitial adenosine level-elevating agents
12/20/2000EP1060739A1 Slimming cosmetic composition containing L-arginine or a derivative thereof
12/20/2000EP1060673A1 Method for increasing the production of propionate in the gastro-intestinal tract
12/20/2000EP1060259A2 Novel means and methods for the preparation and activation of nucleoside and nucleotide based drugs
12/20/2000EP1060254A2 Human proteinase molecules
12/20/2000EP1060188A1 Cholenic acid amides and pharmaceutical compositions thereof
12/20/2000EP1060187A1 S-substituted 11beta-benzaldoxime-estra-4,9-diene-carbonic acid thiolesters, method for the production thereof and pharmaceutical preparations containing these compounds
12/20/2000EP1060186A1 20-keto-11beta-arylsteroids and their derivatives having agonist or antagonist hormonal properties
12/20/2000EP1060183A1 5'-deoxycytidine derivatives
12/20/2000EP1060182A2 Novel prodrugs for phosphorus-containing compounds
12/20/2000EP1060181A1 Substituted pyrrolobenzimidazoles for treating inflammatory diseases
1 ... 6189 6190 6191 6192 6193 6194 6195 6196 6197 6198 6199 6200 6201 6202 6203 6204 6205 6206 6207 6208 6209 ... 7860